Tech Company Financing Transactions
Cognition Therapeutics Funding Round
Private investors participated in a $3.5 million funding round for Cognition Therapeutics. This venture round was announced by the company on 4/1/2016.
Transaction Overview
Company Name
Announced On
4/1/2016
Transaction Type
Debt
Amount
$3,470,072
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 41 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2403 Sidney St. 261
Pittsburgh, PA 15203
USA
Pittsburgh, PA 15203
USA
Phone
Website
Email Address
Overview
Cognition Therapeutics develops new therapeutics to treat patients suffering from Alzheimers disease and other neurodegenerative disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kenneth Moch
Chief Financial Officer
Stephen DiPalma
Chief Medical Officer
Gilbert Rishton
Chief Scientific Officer
Susan Catalano
Browse more venture capital transactions:
Prev: 3/31/2016: Natero venture capital transaction
Next: 4/1/2016: Branch venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs